Lv31
220 积分 2025-04-21 加入
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
10天前
已完结
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
10天前
已完结
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
1个月前
已完结
Cefiderocol: the Trojan horse has arrived but will Troy fall?
1个月前
已完结
Cefiderocol: Clinical application and emergence of resistance
1个月前
已完结
Realizing the promise of CAR-T cell therapies for autoimmune diseases
1个月前
已完结
Shifts in pharma’s therapeutic area focus
1个月前
已完结
Designing GPCR-targeted miniproteins
1个月前
已完结
Evolution of the psoriasis therapy landscape
1个月前
已完结
Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial
1个月前
已完结
皖公网安备34019202002308
